Hospital admissions for severe infections in people with chronic kidney disease in relation to renal disease severity and diabetes status

Endocrinology, Diabetes & Metabolism
Ellen BerniCraig J Currie

Abstract

Immunosuppressive agents are being investigated for the treatment of chronic kidney disease (CKD) but may increase risk of infection. This was a retrospective observational study intended to evaluate the risk of hospitalized infection in patients with CKD, by estimated glomerular filtration rate (eGFR) and proteinuria status, aiming to identify the most appropriate disease stage for immunosuppressive intervention. Routine UK primary-care and linked secondary-care data were extracted from the Clinical Practice Research Datalink. Patients with a record of CKD were identified and grouped into type 2, type 1 and nondiabetes cohorts. Time-dependent, Cox proportional hazard models were used to determine the likelihood of hospitalized infection. We identified 97 839 patients with a record of CKD, of these 11 719 (12%) had type 2 diabetes. In these latter patients, the adjusted hazard ratios (aHR) were 1.00 (95% CI: 0.80-1.25), 1.00, 1.03 (95% CI: 0.92-1.15), 1.36 (95% CI: 0.20-1.54), 1.82 (95% CI: 1.54-2.15) and 2.41 (95% CI: 1.60-3.63) at eGFR stages G1, G2 (reference), G3a, G3b, G4 and G5, respectively; and 1.00, 1.45 (95% CI: 1.29-1.63) and 1.91 (95% CI: 1.67-2.20) at proteinuria stages A1 (reference), A2 and A3, respectively. All ...Continue Reading

References

Jan 1, 1997·Kidney International·G RemuzziA Benigni
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Jun 24, 2003·Journal of the American Society of Nephrology : JASN·Michael AllonUNKNOWN HEMO Study Group
Jul 12, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L M A J MullerG E H M Rutten
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Sep 13, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Lorien S DalrympleMichael G Shlipak
Sep 13, 2012·Mediators of Inflammation·Andy K H Lim, Gregory H Tesch
Jun 1, 2013·Current Opinion in Pharmacology·Fionnuala B Hickey, Finian Martin
Jun 4, 2013·Lancet·Vivekanand JhaChih-Wei Yang
Feb 3, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Helen I McDonaldDorothea Nitsch
Mar 19, 2015·Journal of Diabetes Research·Javier Donate-CorreaJuan F Navarro-González
Apr 22, 2015·BMJ Open Diabetes Research & Care·Huifang LiangPaul Dolin
Jun 8, 2015·International Journal of Epidemiology·Emily HerrettLiam Smeeth
Sep 28, 2015·Diabetologia·Roberto BassiPaolo Fiorina
Jul 22, 2016·American Journal of Physiology. Renal Physiology·Marcela HerreraCarol Moreno Quinn
Aug 26, 2016·American Journal of Physiology. Renal Physiology·Raimund PichlerKatherine R Tuttle

❮ Previous
Next ❯

Citations

May 3, 2019·Diabetes, Obesity & Metabolism·Richard E Gilbert, Kevin E Thorpe
Apr 29, 2020·Journal of Clinical Medicine·Wen-Chin LeeChien-Te Lee

❮ Previous
Next ❯

Software Mentioned

R

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.